[Treatment of in situ ductal cancers of the breast].
According to the most recent studies reported in the literature, and those carried out in a trial carried out in Grenoble and Lyon (France) involving 210 in situ cancers of the breast, the respective indications for conservative and radical treatment are proposed for in situ duct cancers. The preferred orientation towards the most conservative treatment possible can be decided only after the prospective studies which are currently being evaluated in both the USA and in Europe.
Rochet
Y
Y
Départment de Gynécologie, Oncologie Gynécologique, Sénologie et Médecine de la Reproduction, Hôpital Edouart-Herriot, Lyon.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D002278:Carcinoma in Situ / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008408:Mastectomy / Q000592:standards; D011878:Radiotherapy / Q000592:standards
Le traitement des cancers canalaires in situ du sein.